Severe Bone Marrow Aplasia Following Macrophage Activation Syndrome in Systemic Lupus Erythematosus

被引:1
作者
Ichimura, Hirona [1 ]
Ichikawa, Satoshi [1 ]
Ono, Koya [1 ]
Inokura, Kyoko [1 ]
Hoshi, Yosuke [2 ]
Shirai, Tsuyoshi [2 ]
Fukuhara, Noriko [1 ]
Yokoyama, Hisayuki [1 ]
Fujii, Hiroshi [2 ]
Harigae, Hideo [1 ]
机构
[1] Tohoku Univ Hosp, Dept Hematol, 1-1 Seiryo Machi,Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ Hosp, Dept Rheumatol, Sendai, Miyagi, Japan
关键词
aplastic anemia; hemophagocytic lymphohistiocytosis; macrophage activation syndrome; severe bone marrow aplasia; systemic lupus erythematosus;
D O I
10.1620/tjem.2023.J037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Macrophage activation syndrome (MAS) is a potentially fatal complication of rheumatic diseases, characterized by activated macrophages with hemophagocytosis and multiple organ damage. We report a case of MAS associated with systemic lupus erythematosus that initially presented with severe liver dysfunction. Although it was improved with steroids and plasmapheresis, severe pancytopenia was subsequently experienced, and the bone marrow showed severe aplasia similar to aplastic anemia. Nevertheless, the administration of immunosuppressants resulted in the recovery of blood counts within two weeks. When severe MAS results in cytokine overproduction, bone marrow aplasia may occur, for which immunosuppressive therapy may be highly effective.
引用
收藏
页码:301 / 304
页数:4
相关论文
共 17 条
[1]   Exploring Macrophage Activation Syndrome Secondary to Systemic Lupus Erythematosus in Adults: A Systematic Review of the Literature [J].
Aziz, Afia ;
Castaneda, Everardo E. ;
Ahmad, Noorain ;
Veerapalli, Harish ;
Rockferry, Amy G. ;
Lankala, Chetan Reddy ;
Hamid, Pousette .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
[2]   Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment [J].
Carter, Stuart J. ;
Tattersall, Rachel S. ;
Ramanan, Athimalaipet V. .
RHEUMATOLOGY, 2019, 58 (01) :5-17
[3]   Efficacy of plasma exchange on top of standard immunosuppressive therapy in adult autoimmune inflammatory rheumatic diseases-associated macrophage activation syndrome, a single center real-world analysis [J].
Chen, Yuxue ;
Hu, Ziwei ;
Cai, Shaozhe ;
Shen, Guifen ;
Zhong, Jixin ;
Dong, Lingli .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2022, 55
[4]   Macrophage Activation Syndrome as Onset of Systemic Lupus Erythematosus: A Case Report and a Review of the Literature [J].
Granata, Guido ;
Didona, Dario ;
Stifano, Giuseppina ;
Feola, Aldo ;
Granata, Massimo .
CASE REPORTS IN MEDICINE, 2015, 2015
[5]   Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy [J].
Griffin, Georgia ;
Shenoi, Susan ;
Hughes, Grant C. .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2020, 34 (04)
[6]   HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis [J].
Henter, Jan-Inge ;
Horne, AnnaCarin ;
Arico, Maurizio ;
Egeler, R. Maarten ;
Filipovich, Alexandra H. ;
Imashuku, Shinsaku ;
Ladisch, Stephan ;
McClain, Ken ;
Webb, David ;
Winiarski, Jacek ;
Janka, Gritta .
PEDIATRIC BLOOD & CANCER, 2007, 48 (02) :124-131
[7]  
Henter JI, 1997, MED PEDIATR ONCOL, V28, P342, DOI 10.1002/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO
[8]  
2-H
[9]   How I treat hemophagocytic lymphohistiocytosis [J].
Jordan, Michael B. ;
Allen, Carl E. ;
Weitzman, Sheila ;
Filipovich, Alexandra H. ;
McClain, Kenneth L. .
BLOOD, 2011, 118 (15) :4041-4052
[10]   Immunosuppressive therapy with antithymocyte globulin and cyclosporine for prolonged marrow failure after hemophagocytic syndrome [J].
Kaito, K ;
Otsubo, H ;
Takei, Y ;
Usui, N ;
Kobayashi, M .
ANNALS OF HEMATOLOGY, 2003, 82 (11) :699-701